Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (531-540 of 551) with videos related to

Pageof 56
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.
Kidney International|March 31, 2006
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw, D Ramjit, Z Zhang, et al.
Transplantation|February 7, 2001
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantG Dotti, R Fiocchi, T Motta, et al.
Prostaglandins|July 1, 1980
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaG Remuzzi, D Marchesi, C Zoja, et al.
The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.
Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.
Pageof 56

Showing results (531-540 of 551) with videos related to

Sort By:
Pageof 56
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.
Kidney International|March 31, 2006
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw, D Ramjit, Z Zhang, et al.
Transplantation|February 7, 2001
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantG Dotti, R Fiocchi, T Motta, et al.
Prostaglandins|July 1, 1980
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaG Remuzzi, D Marchesi, C Zoja, et al.
The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.
Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.
Pageof 56